CAS 13957-36-3

Meladrazine

Description:

Meladrazine, with the CAS number 13957-36-3, is a chemical compound that belongs to the class of hydrazines. It is characterized by its hydrazine functional group, which consists of two nitrogen atoms connected by a single bond, and is typically associated with various biological and pharmaceutical applications. Meladrazine is known for its potential use in the treatment of certain medical conditions, particularly in the context of its neuroprotective and anti-inflammatory properties. The compound may exhibit a range of physical and chemical properties, including solubility in polar solvents and stability under specific conditions. Its reactivity can be influenced by the presence of functional groups and the molecular structure, making it a subject of interest in medicinal chemistry. As with many hydrazine derivatives, safety precautions are essential when handling Meladrazine due to its potential toxicity and reactivity. Further research is often conducted to explore its efficacy and safety profile in various applications.

Formula: C₁₁H₂₃N₇

InChI: InChI=1S/C11H23N7/c1-5-17(6-2)10-13-9(16-12)14-11(15-10)18(7-3)8-4/h5-8,12H2,1-4H3,(H,13,14,15,16)

InChI key: InChIKey=IRQOBYXMACIFKD-UHFFFAOYSA-N

SMILES: N(CC)(CC)C=1NC(N(CC)CC)=NC(=NN)N1

Synonyms:

• 1,3,5-Triazine-2,4-diamine, N2,N2,N4,N4-tetraethyl-6-hydrazinyl-
• Ciba 13155
• N2,N2,N4,N4-Tetraethyl-6-hydrazinyl-1,3,5-triazine-2,4-diamine
• s-Triazine, 2,4-bis(diethylamino)-6-hydrazino-
• 1,3,5-Triazin-2(1H)-one, 4,6-bis(diethylamino)-, hydrazone

N2,N2,N4,N4-Tetraethyl-6-hydrazono-3,6-dihydro-1,3,5-triazine-2,4-diamine

CAS: 13957-36-3

N2,N2,N4,N4-Tetraethyl-6-hydrazono-3,6-dihydro-1,3,5-triazine-2,4-diamine

Purity: 96%

Molecular weight: 253.35g/mol

Ref: 54-OR1065466

N2,N2,N4,N4-Tetraethyl-6-hydrazinylidene-3,6-dihydro-1,3,5-triazine-2,4-diamine

CAS: 13957-36-3

Tetrodotoxin is a potent neurotoxin that blocks the transfer of nerve impulses. It is used as a pharmacological treatment for diseases of the urinary tract such as bladder and urethral spasms, bladder dysfunction, and urinary retention. Tetrodotoxin can also be used for the treatment of other conditions that affect the target tissue such as stenosis or cavity. This drug has been shown to be beneficial in autoimmune diseases, inflammatory diseases, and infections. Tetrodotoxin is implanted into the body through devices such as catheters or balloons to treat these conditions. The drug has anticholinergic properties which may cause side effects like dry mouth, blurred vision, difficulty urinating, and dizziness.

Formula: C₁₁H₂₃N₇

Purity: Min. 95%

Molecular weight: 253.35 g/mol

Ref: 3D-NAA95736